OCUGEN INC. - COMMON

Ocugen CEO to Present at NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference

29 نوفمبر 2023 07:30:12 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating the Safety and Efficacy of OCU410ST—Modifier Gene Therapy—for Stargardt Disease

10 نوفمبر 2023 07:30:37 بحسب Nasdaq GlobeNewswire

Ocugen Provides Business Update with Third Quarter 2023 Financial Results

09 نوفمبر 2023 06:30:00 بحسب Nasdaq GlobeNewswire

Ocugen CSO to Participate in 4th Annual Dry AMD Therapeutic Development Summit

07 نوفمبر 2023 07:45:14 بحسب Nasdaq GlobeNewswire

Ocugen to Host Conference Call on Thursday, November 9 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2023 Financial Results

02 نوفمبر 2023 07:30:06 بحسب Nasdaq GlobeNewswire

Ocugen Mucosal Vaccine Candidate OCU500 Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials

10 أكتوبر 2023 06:30:48 بحسب Nasdaq GlobeNewswire

Ocugen to Present at the 2023 Cell & Gene Meeting on the Mesa

04 أكتوبر 2023 07:00:20 بحسب Nasdaq GlobeNewswire

Ocugen CSO to Participate in 4th Annual Gene Therapy for Ophthalmic Disorders Conference

29 سبتمبر 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Ocugen to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conference

27 سبتمبر 2023 19:30:50 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces Connie Collingsworth Joins Business Advisory Board

21 سبتمبر 2023 07:30:40 بحسب Nasdaq GlobeNewswire

Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023

20 سبتمبر 2023 08:00:24 بحسب Nasdaq GlobeNewswire

Ocugen Announces Positive Clinical Study Update from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa (RP) and Leber Congenital Amaurosis (LCA)

13 سبتمبر 2023 08:15:19 بحسب Nasdaq GlobeNewswire

Ocugen to Host Virtual Investor & Analyst Event on September 13, 2023

12 سبتمبر 2023 19:30:24 بحسب Nasdaq GlobeNewswire

Ocugen Provides Business Update with Second Quarter 2023 Financial Results

21 أغسطس 2023 16:32:21 بحسب Nasdaq GlobeNewswire

Ocugen to Host Conference Call on Tuesday, August 22 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2023 Financial Results

18 أغسطس 2023 16:39:06 بحسب Nasdaq GlobeNewswire

Ocugen CEO & CSO to Present at 41st Annual AAPI Convention and Scientific Assembly

30 يونيو 2023 08:00:19 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces Adjournment of Annual Meeting of Shareholders

09 يونيو 2023 16:05:12 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces Business Advisory Board

05 يونيو 2023 07:02:25 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces Pricing of $16.5 Million Public Offering of Common Stock

24 مايو 2023 08:36:07 بحسب Nasdaq GlobeNewswire

Ocugen, Inc. Announces Proposed Public Offering of Common Stock

23 مايو 2023 16:01:00 بحسب Nasdaq GlobeNewswire